This Study describes eleven patients positive for severe acute respiratory syndrome coronavirus 2. In our cases, females and younger patients developed more severe disease. In contrast, improvement in left ventricular ejection fraction and N-terminal prohormone brain natriuretic peptide within the first week of treatment contributed to promising outcomes.
Keywords: COVID‐19; NT‐proBNP; SARS‐CoV‐2; echocardiography; myocarditis.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.